Patient
SITE014-0137
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE014 (NLD) (Dr. Moreau)
consented 2026-02-13
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 3
Grade 3 Alopecia — outcome: UNKNOWN; onset 2023-02-28 (study day 195); relationship: not assessed
Grade 1 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2023-02-11 (study day 178); relationship: NOT RELATED
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-09-09 (study day 23); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.